Neutrophil-to-high-density lipoprotein cholesterol ratio

1. Neutrophil-to-high-density lipoprotein cholesterol ratio predicts mortality in humans (AUC: 0.874 (1-year), 0.853 (5-year), 0.877 (9-year)).

   Humansin individuals with asthma

   Neutrophil to High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality Among Asthmatic Individuals: A Cohort Study

   Mediators of inflammation·1 Jan 2026

2. Neutrophil-to-high-density lipoprotein cholesterol ratio raises the risk of mortality in humans (HR: 1.12, 95% CI: 1.03-1.22).

   Humansin asthma patients

   Neutrophil to High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality Among Asthmatic Individuals: A Cohort Study

   Mediators of inflammation·1 Jan 2026

1. Neutrophil-to-high-density lipoprotein cholesterol ratio is associated with early vascular aging in humans (OR 1.583, 95% CI: 1.078-2.327).

   Humans

   Association of the Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Platelet to High-Density Lipoprotein Cholesterol Ratio with Early Vascular Aging

   Journal of inflammation research·13 Aug 2026

1. Neutrophil-to-high-density lipoprotein cholesterol ratio is associated with cardiometabolic multimorbidity in humans (OR 2.33, 95% CI: 1.56-3.48).

   Humanscomparing Q4 to Q1n = 5,987

   Neutrophil-to-high-density lipoprotein cholesterol ratio and prevalent cardiometabolic multimorbidity in older adults: an exploratory cross-sectional analysis

   BMC endocrine disorders·8 Aug 2026

More on Cardiometabolic multimorbidity